Garrett W. Thrash

Garrett W. Thrash

Auto-generated profile, based on publicly available information

Garrett W. Thrash

University of Alabama at Birmingham Heersink School of Medicine, Birmingham, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Bioelectronic Medicine
Verified
Journal Article
Open access
PDF file
GTGarrett W. Thrash
Garrett W. Thrash
EWElijah Wang
Elijah Wang
YSYifei Sun
Yifei Sun
HWHarrison C. Walker
Harrison C. Walker
PSPrasad Shirvalkar
Prasad Shirvalkar
MHMarshall T. Holland
Marshall T. Holland
Background: Drug-resistant hypertension affects approximately 9–18% of the United States hypertensive population. Recognized as hypertension that is resistant to three or more medications, drug-resistant hypertension can lead to fatal sequelae, such as heart failure, aortic dissection, and other vast systemic disease. The disruption of the homeostatic mechanisms that stabilize blood pressure can be treated procedurally when medication fails. These procedures include carotid body stimulation, renal denervation, sympathectomies, dorsal root ganglia stimulation, and more recently spinal cord stimulation and have all been utilized in the treatment of drug-resistant hypertension. Methods: To identify the clinical trials of neuromodulation in drug-resistant hypertension, a PubMed search was performed that included all original clinical trials of neuromodulation treating drug-resistant hypertension. The 838 articles found were sorted using Covidence to find 33 unique primary clinical trials. There were no methods used to assess risk of bias as a meta-analysis was not feasible due to heterogeneity. Results: Renal denervation and carotid body stimulation have both shown promising results with multiple clinical trials, while sympathectomies have mostly been retired due to the irreversible adverse effects caused. Dorsal root ganglion stimulation showed varying success rates. Spinal cord stimulation is a novel treatment of drug-resistant hypertension that shows promising initial results but requires further investigation and prospective studies of the treatment to provide guidelines for future DRH treatment. The limitations of the review are reporting bias and absence of a meta-analysis that compares the treatment modality due to the heterogeneity of reported outcomes. Conclusion: Innovation in neuromodulation is necessary to provide alternative avenues of treatment in the face of contraindications for standard treatment. Treatment of drug-resistant hypertension is essential to delay dangerous sequelae. This review’s objective is to summarize the clinical trials for treatment of drug-resistant hypertension following PRISMA guidelines and suggests future directions in the treatment of drug-resistant hypertension.

11 December 2025 in Neurosurgical Review
Verified
Journal Article
Open access
PDF file
EREllianne dos Santos Rubio
Ellianne dos Santos Rubio
KBKhalil St. Brice
Khalil St. Brice
FTFelix Toussaint
Felix Toussaint
JCJimena Colado-Martinez
Jimena Colado-Martinez
GTGarrett W. Thrash
Garrett W. Thrash
WJWalt Johnson
Walt Johnson

26 August 2026 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
FTFelix Toussaint
Felix Toussaint
EREllieanne Jacira dos Santos Rubio
Ellieanne Jacira dos Santos Rubio
CAChibueze Agwu
Chibueze Agwu
FYForough Yazdanian
Forough Yazdanian
GTGarrett W. Thrash
Garrett W. Thrash
WJWalter D. Johnson
Walter D. Johnson
Background: Global Neurosurgery, galvanized by the 2016 Bogotá Declaration, seeks to address profound disparities in neurosurgical care access. Non-governmental organizations (NGOs) are pivotal yet underexplored actors in this field. This scoping review aims to systematically identify and characterize the landscape of NGOs contributing to global neurosurgery, analyzing their roles, strategies, and gaps. Methods: We conducted a structured search of PubMed, Embase, Global Index Medicus, and grey literature sources following scoping review guidelines. NGOs with a multinational scope, neurosurgical focus, and at least five years of activity were included. Data from websites, reports, and publications were extracted and analyzed thematically. Results: We identified 33 NGOs, categorized as neurosurgery-dedicated, global surgery-inclusive, or neurology-inclusive. Their contributions span direct surgical service, innovative training such as virtual hackathons and dyad-based partnerships, research capacity building, and policy advocacy including folate fortification campaigns. Analysis reveals strengths in partnership models and surgical education, but also critical gaps: uneven geographic coverage, particularly in Francophone Africa and Southeast Asia; a lack of published outcome metrics; and minimal evidence of formal collaboration networks between NGOs. Conclusion: This review provides the first consolidated mapping of the NGO ecosystem in global neurosurgery. To maximize impact, we recommend the establishment of a centralized collaborative platform, the adoption of standardized outcome reporting, and strategic efforts to address identified geographic and programmatic gaps. Future success depends on moving from isolated efforts to an integrated, accountable, and data-driven coalition. Clinical Trial Number: Not applicable.

31 October 2025 in Neurosurgical Review
Verified
Journal Article
Open access
PDF file
EREllianne Santos Dos Rubio
Ellianne Santos Dos Rubio
KBKhalil St Brice
Khalil St Brice
FTFelix Toussaint
Felix Toussaint
JCJimena Colado-Martinez
Jimena Colado-Martinez
GTGarrett W Thrash
Garrett W Thrash
WJWalt Johnson
Walt Johnson
Governmental organizations play a key role in making Global Neurosurgery timely, safe, and accessible. They are essential in decreasing disparity and improving outcomes through informing policy, funding, and resource allocation. The Boston Declaration aims to promote collaboration between high-income and low- and middle-income countries in addressing these challenges and realizing more equitable access to neurosurgical care worldwide. To identify and map key governmental stakeholders in Global Neurosurgery, emphasizing their roles in policy development, funding, resource allocation, research support, capacity building, advocacy, and international cooperation in addressing unmet neurosurgical needs. We employed a mixed-methods approach, analyzing the roles of governmental organizations in neurosurgery. A comprehensive literature review was conducted using PubMed, Embase, and Global Index Medicus. Sources included Ministries of Health and National Institute of Neurological Disorders and Stroke (NINDS) websites, annual reports, social media, and world health organisation (WHO) documents. Inclusion criteria covered governmental organizations and health policy institutions; non-governmental organizations and those without documented impact were excluded. WHO was the most frequently cited organization (25%) guiding global neurosurgical policy. National Ministries of Health (23%) were pivotal in developing policy based on country-specific needs. Centers for Medicare and Medicaid Services were cited in 18%, reflecting their funding role in the U.S., while military health systems (7%) were accountable for trauma care. International partnerships, though less frequent (5%), played vital roles in improving access in low-resource settings. Government agencies like the WHO, Ministries of Health, and Centers for Medicare and Medicaid Services (CMS) advance Global Neurosurgery via policy, financing, and service provision. This underscores the urgent need for sustained collaboration, implementation teams, and accountability to achieve long-term equity.

21 September 2026 in Neuroradiology
Verified
Journal Article
Open access
PDF file
GTGarrett W Thrash
Garrett W Thrash
BDBluyé DeMessie
Bluyé DeMessie
EWElijah L Wang
Elijah L Wang
JJJesse G Jones
Jesse G Jones
MEMuhammed Amir Essibayi
Muhammed Amir Essibayi
Adam DmytriwAdam Dmytriw
Adam Dmytriw
Introduction: Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. Objective: To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. Methods: We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. Results: While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0–3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0–2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26–2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. Conclusion: Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.

1 October 2026 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
YSYifei Sun
Yifei Sun
HRHariteja Ramapuram
Hariteja Ramapuram
BBBryant Barrentine
Bryant Barrentine
GTGarrett W. Thrash
Garrett W. Thrash
MHMohammad Hamo
Mohammad Hamo
DEDagoberto Estevez-Ordonez
Dagoberto Estevez-Ordonez
Background and objectives: Endoscopic transsphenoidal surgery is a common modality of pituitary adenoma resection. Recent evidence has suggested that socioeconomic disparities exist in outcomes of these operations. However, there exists limited evidence regarding the association between neighborhood socioeconomic disadvantage and outcomes following pituitary adenoma resection utilizing a transsphenoidal approach. We sought to investigate the impact of neighborhood disadvantage on outcomes following transsphenoidal pituitary adenoma resection. Methods: We retrospectively reviewed all adult patients at a single institution from 2012 to 2024 who underwent endoscopic transsphenoidal resection of pituitary adenomas. Patient addresses underwent geospatial analysis and Area Deprivation Index (ADI) was extracted, with patients in the top 90th percentile defined as having high socioeconomic deprivation. Univariable comparison and logistic regressions were utilized to assess the relationship between socioeconomic factors and length of stay, readmissions, and endocrine outcomes. Results: In total, 756 patients [median age 56 years (Interquartile range [IQR] 44–66)] met the inclusion criteria. The median ADI of the cohort was 74 (IQR 53–87). Patients who had high neighborhood disadvantage had larger tumor volumes compared to white patients at presentation (5.0 cm 3 vs 3.9 cm 3 , p = .01). Upon multivariable logistic regression, high neighborhood disadvantage (OR 3.51, 95%CI 1.53–7.98), postoperative hyponatremia (OR 3.87, 95% CI 1.88–8.24), postoperative diabetes insipidus (OR 5.7, 95%CI 2.73–12.4), and being uninsured (OR 4.31, 95%CI 1.05–15.8) were found to be associated with increased odds of prolonged length of stay. Being uninsured was also associated with delayed postoperative hyponatremia (OR 5.38, 95%CI 1.25–19.9), while delayed hyponatremia was associated with increased odds of 30-day readmission (OR 3.35, 95% CI 1.19–8.67). Conclusions: We present the first study reporting the effect of neighborhood-level socioeconomic status on outcomes following transsphenoidal pituitary adenoma resection. Socioeconomic status plays a complex role in surgical outcomes. Further research should focus on underlying drivers of disparities in outcomes in this population.